Wednesday, 1 April, 2020
CEPI (Coalition for Epidemic Preparedness Innovations) is a global partnership between public, private, philanthropic, and civil organisations to develop vaccines to stop future epidemics. In coordination with the World Health Organization (WHO), as it leads the development of a coordinated international response, CEPI is promoting the development of new vaccines against the emerging threat of COVID-19.
This call for expressions of interest requests nformation from entities able to serve as possible sponsors or to provide operational trial support (Clinical Research Organizations) for clinical trials involving vaccine candidates against COVID-19.
CEPI has funded several COVID-19 vaccine development projects and intends to broaden this portfolio of vaccine candidates further. It will also consider supporting trials for vaccines that have not previously received CEPI support. In anticipation of clinical trials of COVID-19 vaccines, CEPI is seeking to identify, in advance of need, entities that could serve as sponsors or provide clinical research organization (CRO) support for such trials. It is envisioned that in many circumstances, the developer would be the sponsor of a trial but may need CRO support. It is also anticipated that some trials may include more than one vaccine and use a shared control or comparator group; in this case, a single company cannot be the sponsor and a neutral entity will need to fill that role. For the latter circumstance, CEPI is seeking to identify potential sponsors as well as CROs.
Since it is not yet clear where (in what countries) trials will be conducted, information is being requested from applicants with either country, regional or global reach. Applications from LMIC based entities are encouraged.
Following an evaluation process, CEPI will implement framework agreements with one or more sponsors and CROs.
Sponsors may be a non-profit or for-profit organisation, product development partnership, government research organisation or intergovernmental organisation. Sponsors and CROs must be legal entities with experience in clinical trials with human vaccines.
Following an evaluation, CEPI will implement framework agreements with one or more sponsors and CROs.
Expressions of Interest should be submitted by the deadline of 19 April 2020 (15:00 CET).
More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.